Griffin: Accessing functional antibodies from serum without B cells

May 20, 2025 | Science, Services

Griffin is a platform for sequencing polyclonal antibodies using mass spectrometry. Since 2009, Abterra Biosciencs founders and employees have been developing novel methods for sequencing antibody proteins directly. Our monoclonal antibody sequencing service, Valens, has been used to successfully sequence hundreds of antibodies without the need for B cells. Now, with Griffin, we can sequencing complex mixes of antibodies directly from patient serum, or from immunized animals.

Watch our CEO, Dr. Natalie Castellana’s presentation on Unlocking the Serum Antibody Repertoire: Accessing Functional Antibodies without B Cells to learn how Griffin works.

Click below to watch the presentation.

Case Study: Reptor Biological vs Technical Replicates

Replicates of immune repertoire sequencing projects can provide invaluable information about the total diversity of a sample.

Abterra Opens Its Doors To Celebrate New Location With Open House

Celebrating milestones is an important part of our personal and professional journeys. We wanted to commemorate this exciting new chapter in Abterra's story with the people who mean the most to us: our devoted employees, cherished families, esteemed investors, and...